(Q46191457)

20 December 2017

title

Effects of polymorphism of the beta(1) adrenoreceptor and CYP2D6 on the therapeutic effects of metoprolol (English)

1 reference

20 December 2017

author name string

H Yuan

1

1 reference

20 December 2017

Z Huang

2

1 reference

20 December 2017

G Yang

3

1 reference

20 December 2017

H Lv

4

1 reference

20 December 2017

H Sang

5

1 reference

20 December 2017

Y Yao

6

1 reference

20 December 2017

publication date

1 November 2008

1 reference

20 December 2017

Journal of International Medical Research

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

20 December 2017

volume

36

1 reference

20 December 2017

issue

6

1 reference

20 December 2017

page(s)

1354-1362

1 reference

20 December 2017

The genetic dissection of essential hypertension

cites work

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Genetics of hypertension: from experimental models to clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Cardiac effects of beta-adrenergic receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Catecholamines and the kidney: receptors and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

The functional significance of genetic variation within the beta-adrenoceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Effect of CYP2D6*10 on pharmacokinetic variability of routinely administered metoprolol in middle-aged and elderly Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Pharmacogenetics of beta-1- and beta-2-adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Drug reactions enzymes, and biochemical genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Antihypertensive pharmacogenetics: getting the right drug into the right patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Association of the C-344T aldosterone synthase gene variant with essential hypertension: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Clinical pharmacokinetics of metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Gly389Arg polymorphism of β1-adrenergic receptor is associated with the cardiovascular response to metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

10.1177/147323000803600624

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017